LINCOLN PHARMA
LINCOLN · NSE
509.90
-48.20 (-8.64%)
as of 29 Oct 2026 close
Open
561.00
High
567.95
Low
505.00
Prev close
558.10
52w high
770.00
27 May 2026
52w low
440.00
28 Jan 2026
VWAP
518.42
Delivery %
19.1%
of volume
Volume 4.82 L · turnover ₹25.01 Cr · NSE bhavcopy (official close) · history since 17 Dec 2015
- ISIN
- INE405C01035
- Series
- EQ
- Listed on NSE
- 17 Dec 2015
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Moving averages & momentum · as of 29 Oct 2026 close
| SMA 20 | 547.65 |
| SMA 50 | 585.72 |
| SMA 200 | 593.14 |
| RSI 14 | 35.7 |
| ATR 14 | 25.94 |
How these are computed
SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.
52-week position · as of 29 Oct 2026 close
440.00 28 Jan 202621% of range770.00 27 May 2026
Returns · close to close
1w
-0.19%
1m
-12.37%
3m
-12.30%
6m
-21.11%
1y
-3.31%
Corporate actions · latest 11 · NSE
| 11 Sept 2026 | Dividend | ₹1.8/share |
| 12 Sept 2025 | Dividend | ₹1.8/share |
| 13 Sept 2024 | Dividend | ₹1.8/share |
| 15 Sept 2023 | Dividend | ₹1.5/share |
| 15 Sept 2022 | Dividend | ₹1.5/share |
| 16 Sept 2021 | Dividend | ₹1.5/share |
| 05 Mar 2020 | Dividend | ₹1.5/share |
| 19 Sept 2019 | Dividend | ₹1.5/share |
| 19 Sept 2018 | Dividend | ₹1.5/share |
| 21 Sept 2017 | Dividend | ₹1.2/share |
| 23 Sept 2016 | Dividend | ₹1/share |
Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.